Bavarian Nordic

This is a large, late-stage study to test a new vaccine designed to prevent chikungunya, a painful mosquito-borne illness. It will enroll over 6,000 healthy adolescents and adults who have not had chikungunya before. The main goal is to see if the vaccine safely prevents people f…